This article is from the source 'guardian' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.theguardian.com/society/2018/feb/04/women-called-back-in-after-review-of-cervical-cancer-screening-lab

The article has changed 6 times. There is an RSS feed of changes available.

Version 0 Version 1
Women called back in after review of cervical cancer screening lab Women called back in after review of cervical cancer screening lab
(35 minutes later)
NHS trust in Essex is rescreening 2,500 samples, with 17 women so far needing reassessment after problem with testsNHS trust in Essex is rescreening 2,500 samples, with 17 women so far needing reassessment after problem with tests
Patrick Greenfield and agenciesPatrick Greenfield and agencies
Sun 4 Feb 2018 22.32 GMTSun 4 Feb 2018 22.32 GMT
Last modified on Sun 4 Feb 2018 22.41 GMT Last modified on Sun 4 Feb 2018 23.07 GMT
Share on FacebookShare on Facebook
Share on TwitterShare on Twitter
Share via EmailShare via Email
View more sharing optionsView more sharing options
Share on LinkedInShare on LinkedIn
Share on PinterestShare on Pinterest
Share on Google+Share on Google+
Share on WhatsAppShare on WhatsApp
Share on MessengerShare on Messenger
CloseClose
Thousands of cervical smear test samples are being reviewed by an independent screening service after an issue was discovered in a laboratory, an Essex NHS trust has announced. Thousands of cervical smear test samples are being reviewed by an independent screening service after a problem was discovered in a laboratory.
Basildon and Thurrock NHS Foundation trust said 2,500 samples from cervical cancer tests were being rescreened after a problem with testing was identified in a routine Public Health England quality assurance visit in June 2017. So far, 900 smear test samples have been reviewed, and 17 women have been invited for further assessment. Of those, nine need to be rescreened while eight have been referred for further investigation. Basildon and Thurrock NHS foundation trust in Essex said 2,500 samples from cervical cancer tests were being rescreened after a problem with testing was identified in a routine Public Health England quality assurance visit in June 2017. So far, 900 smear test samples have been reviewed, and 17 women have been invited for further assessment. Of those, nine need to be rescreened while eight have been referred for further investigation.
“All the women who have so far been identified as needing to be seen again have been notified and their GP informed. Women whose negative result has been confirmed after rescreening will not be contacted as their result has not changed,” the trust said in a statement. We understand that this is a potentially worrying time for the women involved and would like to reassure all women covered by the locally provided cervical screening programme that this was an isolated incident,” it added. “All the women who have so far been identified as needing to be seen again have been notified and their GP informed. Women whose negative result has been confirmed after rescreening will not be contacted as their result has not changed,” the trust said in a statement. “We understand that this is a potentially worrying time for the women involved and would like to reassure all women covered by the locally provided cervical screening programme that this was an isolated incident.”
Pathology First, which runs the laboratory where the issue was discovered, delivers laboratory services to around 750,000 patients and more than 100 GP practices in the south-east. The lab in Basildon, Essex carries out more than 900 different types of test. The affected samples were taken between April 2016 and September 2017 from women aged between 24 and 29 who were undergoing their first smear test, and a number of women in their 60s. Pathology First, which runs the laboratory where the problem was discovered, delivers laboratory services to about 750,000 patients and more than 100 GP practices in the south-east. The lab in Basildon carries out more than 900 different types of test. The affected samples were taken between April 2016 and September 2017 from women aged between 24 and 29 who were undergoing their first smear test, and a number of women in their 60s.
NHS England said there have been changes to local processes and updated staff training to ensure women receive safe, high-quality screening.NHS England said there have been changes to local processes and updated staff training to ensure women receive safe, high-quality screening.
Cervical cancerCervical cancer
NHSNHS
CancerCancer
HealthHealth
newsnews
Share on FacebookShare on Facebook
Share on TwitterShare on Twitter
Share via EmailShare via Email
Share on LinkedInShare on LinkedIn
Share on PinterestShare on Pinterest
Share on Google+Share on Google+
Share on WhatsAppShare on WhatsApp
Share on MessengerShare on Messenger
Reuse this contentReuse this content